Reporter April 24 2020
Apr. 24, 2020—Let’s start today with a topic that I know is top-of-mind: When and — just as important — how will we reopen?
Apr. 23, 2020—The rapid ramping up of SARS-CoV-2 testing at VUMC reflects the dedication of the professionals who work in the Clinical Laboratory and also their collaboration with colleagues in research laboratories throughout VUMC.
Apr. 23, 2020—Compared to last April, through April 19 the adult trauma service at Vanderbilt University Medical Center is on track to admit 65% fewer patients from roadway accidents, including motor vehicle accidents, motorcycle accidents and pedestrians struck by autos.
Apr. 23, 2020—Vanderbilt University Medical Center investigators have joined an international genetics effort to make advances as quickly as possible on understanding and treating COVID-19.
Apr. 23, 2020—Health care workers at Vanderbilt University Medical Center at high risk of exposure to COVID-19 can participate in a randomized, controlled clinical trial testing the effectiveness of the drug hydroxychloroquine (HCQ) in preventing infection.
Apr. 23, 2020—When in-person visits to Vanderbilt Eskind Diabetes Clinic needed to be quickly converted to telehealth appointments in response to COVID-19, a novel solution was hatched to bring both clinicians and patients up to speed on videoconferencing.
Apr. 23, 2020—A team of Vanderbilt researchers constructed polygenic risk scores (PRS) based on genomic variants associated with eight common cancers and concluded they could potentially be used for personalized risk assessments.
Apr. 23, 2020—Vanderbilt University Medical Center is participating in a multisite clinical trial to test a potential new medication for treating core deficits of autism spectrum disorders in children ages 2-4.